Our Article is Now Online in Pharmacological Reviews

Phragma Therapeutics

Phragma TherapeuticsPhragma TherapeuticsPhragma Therapeutics

Phragma Therapeutics

Phragma TherapeuticsPhragma TherapeuticsPhragma Therapeutics

Developing therapeutics for neurological diseases by modulating blood–brain barrier function

Get in touch

Founding Team

Spyros Papapetropoulos, MD, PhD

Spyros Papapetropoulos, MD, PhD

Spyros Papapetropoulos, MD, PhD

Chief Executive Officer, 

Chairman, BoD 

LinkedIn

Sifis Pediaditakis, PhD

Spyros Papapetropoulos, MD, PhD

Spyros Papapetropoulos, MD, PhD

Vice President,

Head of Biology

LinkedIn

Matthew Brennan, MBA

Spyros Papapetropoulos, MD, PhD

William Robinson, MD, PhD

Business Advisor

Director, BoD

LinkedIn

William Robinson, MD, PhD

Andreas Papapetropoulos, PhD, FAHA, FBPhS

William Robinson, MD, PhD

Senior Scientific Advisor,

Director, BoD

LinkedIn

Andreas Papapetropoulos, PhD, FAHA, FBPhS

Andreas Papapetropoulos, PhD, FAHA, FBPhS

Andreas Papapetropoulos, PhD, FAHA, FBPhS

Scientific Advisor


LinkedIn

Get in touch

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Our Partners

Phragma Therapeutics Inc.

134 Coolidge Ave, Watertown, MA 02472, USA

Copyright © 2025 Phragma Therapeutics - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept